Effect of interferon alpha2b plus ribavirin treatment on selected growth factors in respect to inflammation and fibrosis in chronic hepatitis C

doi:10.3748/wjg.v11.i12.1854

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 12

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2390)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-5) series.

Item

Count

PDF

326

HTML

1920

Tables (1-5)

138

Sum=2384

Mar 28, 2005 (publication date) through Jul 22, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Mar 28, 2005; 11(12): 1854-1858
Published online Mar 28, 2005. doi: 10.3748/wjg.v11.i12.1854

Effect of interferon alpha2b plus ribavirin treatment on selected growth factors in respect to inflammation and fibrosis in chronic hepatitis C

Panasiuk Anatol, Flisiak Robert, Prokopowicz Danuta

Panasiuk Anatol, Flisiak Robert, Prokopowicz Danuta, Department of Infectious Diseases, Medical University of Białystok, 15-540 Białystok, Zurawia str., 14, Poland

Author contributions: All authors contributed equally to the work.

Correspondence to: Dr. Panasiuk Anatol, M.D., Department of Infectious Diseases, Medical University of Białystok, 15-540 Białystok, Zurawia str., 14, Poland. anatol@panasiuk.pl

Telephone: +4885-7416-921 Fax: +4885-7416-921

Received: August 18, 2004
Revised: August 20, 2004
Accepted: September 30, 2004
Published online: March 28, 2005

Core Tip